1. Home
  2. WDFC vs TLX Comparison

WDFC vs TLX Comparison

Compare WDFC & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WD-40 Company

WDFC

WD-40 Company

HOLD

Current Price

$240.59

Market Cap

3.2B

Sector

Industrials

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$6.43

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WDFC
TLX
Founded
1953
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WDFC
TLX
Price
$240.59
$6.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$300.00
$21.00
AVG Volume (30 Days)
168.0K
178.9K
Earning Date
01-08-2026
01-19-2026
Dividend Yield
1.70%
N/A
EPS Growth
26.07
N/A
EPS
6.58
0.04
Revenue
$620,913,000.00
$664,225,558.00
Revenue This Year
$7.14
N/A
Revenue Next Year
$6.02
N/A
P/E Ratio
$36.41
$150.68
Revenue Growth
2.86
55.35
52 Week Low
$175.38
$6.40
52 Week High
$253.48
$30.36

Technical Indicators

Market Signals
Indicator
WDFC
TLX
Relative Strength Index (RSI) 65.83 32.32
Support Level $234.19 $6.94
Resistance Level $253.24 $7.43
Average True Range (ATR) 7.04 0.25
MACD 0.51 -0.05
Stochastic Oscillator 65.98 1.46

Price Performance

Historical Comparison
WDFC
TLX

About WDFC WD-40 Company

WD-40 Co is a global marketing organization focused on developing and selling products that solve maintenance and cleaning problems internationally. It offers two product groups: maintenance products, including the flagship WD-40 Multi-Use Product, which serves as a lubricant, rust preventative, penetrant, and moisture displacer, marketed globally; and homecare and cleaning products, mainly sold in North America, the UK, and Australia. The company distributes its products through hardware stores, automotive parts outlets, industrial suppliers, mass retailers, online platforms, and specialty retailers across the Americas, EIMEA, and Asia-Pacific, with the majority of revenue generated in the Americas.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: